Principal Financial Officer, Chief Accounting Officer
Principal Financial Officer, Chief Accounting Officer
4.00K
+5.00%
Dr. Richard R. Green
Dr. Richard R. Green
Independent Director
Independent Director
2.59K
-1.54%
Mr. Brian M. Deevy
Mr. Brian M. Deevy
Independent Director
Independent Director
--
-100.00%
Ms. Renee L. Wilm
Ms. Renee L. Wilm
Chief Legal Officer, Chief Administrative Officer
Chief Legal Officer, Chief Administrative Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John C. Malone, Ph.D.
Dr. John C. Malone, Ph.D.
Chairman of the Board
Chairman of the Board
2.21M
-43.50%
Mr. Ronald A. Duncan
Mr. Ronald A. Duncan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
166.38K
+1.50%
Mr. Jedd Gould
Mr. Jedd Gould
Director
Director
6.00K
+3.98%
Mr. Larry E. Romrell
Mr. Larry E. Romrell
Independent Director
Independent Director
4.14K
-26.52%
Mr. Brian J. Wendling
Mr. Brian J. Wendling
Principal Financial Officer, Chief Accounting Officer
Principal Financial Officer, Chief Accounting Officer
4.00K
+5.00%
Dr. Richard R. Green
Dr. Richard R. Green
Independent Director
Independent Director
2.59K
-1.54%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de GCI Liberty Ord Shs Series C?
Los cinco principales accionistas de GCI Liberty Ord Shs Series C son: Dr. John C. Malone, Ph.D.
¿Cuántas instituciones poseen acciones de GCI Liberty Ord Shs Series C (GLIBK)?
A fecha de 2026Q1, 424 instituciones poseen acciones de GCI Liberty Ord Shs Series C, con un valor de mercado combinado de aproximadamente 38.99M, lo que representa el 108.74% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 12154626.00.
¿Cuál es la mayor fuente de ganancias de GCI Liberty Ord Shs Series C?
El 2026Q1, el segmento empresarial Business Revenue - Data generó la ganancia más alta para GCI Liberty Ord Shs Series C, ascendiendo a 500.00M y representando el 47.80% de la ganancia total.